MetLife Investment Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Hold |
22,766
| – | – | ﹤0.01% | 1936 |
|
|
2025
Q1 | $252K | Hold |
22,766
| – | – | ﹤0.01% | 2077 |
|
|
2024
Q4 | $242K | Buy |
22,766
+2,727
| +14% | +$29K | ﹤0.01% | 2201 |
|
|
2024
Q3 | $254K | Hold |
20,039
| – | – | ﹤0.01% | 2161 |
|
|
2024
Q2 | $336K | Buy |
20,039
+5,413
| +37% | +$90.8K | ﹤0.01% | 1940 |
|
|
2024
Q1 | $219K | Hold |
14,626
| – | – | ﹤0.01% | 2150 |
|
|
2023
Q4 | $219K | Buy |
14,626
+4,223
| +41% | +$63.3K | ﹤0.01% | 2195 |
|
|
2023
Q3 | $146K | Hold |
10,403
| – | – | ﹤0.01% | 2376 |
|
|
2023
Q2 | $108K | Buy |
+10,403
| New | +$108K | ﹤0.01% | 2631 |
|
|
2021
Q4 | – | Sell |
-7,354
| Closed | -$124K | – | 2553 |
|
|
2021
Q3 | $124K | Buy |
+7,354
| New | +$124K | ﹤0.01% | 2346 |
|
|
2021
Q2 | – | Sell |
-8,654
| Closed | -$169K | – | 2489 |
|
|
2021
Q1 | $169K | Sell |
8,654
-1,336
| -13% | -$26K | ﹤0.01% | 2141 |
|
|
2020
Q4 | $180K | Hold |
9,990
| – | – | ﹤0.01% | 2032 |
|
|
2020
Q3 | $193K | Hold |
9,990
| – | – | ﹤0.01% | 1886 |
|
|
2020
Q2 | $261K | Hold |
9,990
| – | – | ﹤0.01% | 1745 |
|
|
2020
Q1 | $178K | Hold |
9,990
| – | – | ﹤0.01% | 1768 |
|
|
2019
Q4 | $333K | Hold |
9,990
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q3 | $238K | Buy |
+9,990
| New | +$238K | ﹤0.01% | 1845 |
|